MEDcounselor Drug Information Now Available on ISMP’s ConsumerMedSafety.org

MEDcounselor’s Drug Information, Drug IDentifier and Drug Interactions Modules Help Consumers Take Medications Safely, Avoid Errors

Tampa, FL – July 20, 2010 – Gold Standard/Elsevier, developer of drug information and medication management solutions, announced today that the Institute for Safe Medication Practices (ISMP) has licensed MEDcounselor Drug Information, Drug IDentifer and Drug Interaction modules for its consumer website, ConsumerMedSafety.org. ISMP is a federally certified patient safety organization that focuses on preventing medication errors and adverse drug events, and offers legal protection and confidentiality for submitted patient safety and error reports.

“As the nation’s only not-for-profit organization of physicians, nurses and pharmacists dedicated exclusively to safe medication practices, ISMP views Gold Standard’s MEDcounselor modules as a valuable tool for empowering consumers to make informed medication decisions and becoming more engaged in their care,” said Michael R. Cohen, RPh, MS, ScD, FASHP, ISMP’s President. “Educating consumers via MEDcounselor supports ISMP in its quest to prevent costly medication errors and advance patient safety worldwide.”

MEDcounselor modules now available via ConsumerMedSafety.org include:

“Gold Standard/Elsevier supports ISMP in its mission to educate the healthcare community and consumers on safe medication practices,” said Marianne Messer, President of Gold Standard. “By accessing MEDcounselor modules on ConsumerMedSafety.org, consumers will get the vital information they need to take drugs safely, identify unknown tablets and capsules, comply with drug regimens and avoid serious medication errors.”

Gold Standard licenses its MEDcounselor modules to pharmacies, consumer health information websites, online communities, health systems and managed care organizations. A specially created “Toolkit” allows organizations to integrate MEDcounselor modules with their existing healthcare content and add search functions and links to drug information from their own Web sites or applications.

“ISMP is truly in the vanguard, offering accessible resources to healthcare consumers who now, more than ever, demand speedy, accurate answers to their medication questions,” said Gold Standard’s Messer. “By partnering with ISMP and ConsumerMedSafety.org, Gold Standard has helped enhance a trusted online resource that millions of healthcare consumers use, value and revisit for life-saving medication insights.”

For more information on MEDcounselor modules, please call 866-417-9150 or email goldstandard@elsevier.com. For more information on how consumers can help prevent medication errors and take their medications safely, visit www.ConsumerMedSafety.org.

# # #

About Gold Standard/Elsevier
Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/Elsevier solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Gold Standard/Elsevier, visit www.goldstandard.com.

About the Institute for Safe Medication Practices
The Institute for Safe Medication Practices (ISMP) is an independent, nonprofit charitable organization that works closely with healthcare practitioners and institutions, regulatory agencies, consumers, and professional organizations to provide education about medication errors and their prevention. ISMP represents more than 35 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. ISMP is a federally certified patient safety organization (PSO), providing healthcare practitioners and organizations with the highest level of legal protection and confidentiality for patient safety data and error reports they submit to the Institute. For more information on ISMP, or its medication safety alert newsletters and other tools for healthcare professionals and consumers, visit www.ismp.org.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact
Tom Reller
Vice President of Global Relations, Elsevier
+1 212 462 1912
t.reller@Elsevier.com